Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Complementary therapies and the management of diabetes and vascular disease [[electronic resource] ] : a matter of balance / / editor, Trish Dunning
| Complementary therapies and the management of diabetes and vascular disease [[electronic resource] ] : a matter of balance / / editor, Trish Dunning |
| Pubbl/distr/stampa | Chichester ; ; New York, : J. Wiley, c2006 |
| Descrizione fisica | 1 online resource (422 p.) |
| Disciplina |
616.462
616.46206 |
| Altri autori (Persone) | DunningTrisha |
| Collana | Diabetes in practice |
| Soggetto topico | Diabetes - Alternative treatment |
| Soggetto genere / forma | Electronic books. |
| ISBN |
1-280-73987-8
9786610739875 0-470-05743-2 0-470-05742-4 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Complementary Therapies and the Management of Diabetes and Vascular Disease; Contents; Preface; Foreword; List of Contributors; Acknowledgements; 1 Introduction to Diabetes; 1.1 Incidence and Prevalence of Diabetes; 1.2 Overview of Diabetes; 1.3 Management Strategies; 1.4 Management Targets and Regimens; 1.5 Short-term Complications; 1.6 Long-term Complications; 1.7 Psychological Aspects; 1.8 Diabetes Management Requires Integrated Approaches; 1.9 People with Diabetes' Needs, Capacities and Resources; 1.10 Health Professionals' Needs; 1.11 Integration - Is It Possible?
1.12 Complementary Therapies1.13 Summary; References; 2 Complementary Therapy Use; 2.1 Introduction; 2.2 Defining Complementary Therapies; 2.3 What Is Traditional Use?; 2.4 Philosophical Basis of CAM; 2.5 Frequency of CAM Use; 2.6 Profile of Likely CAM Users; 2.7 Culture, Health Beliefs and CAM; 2.8 Reported Adverse Events Associated with CAM; 2.9 Summary; References; 3 Complementary Medicine and Safety; 3.1 Introduction; 3.2 Practices; 3.3 Risks and safety; 3.4 Adverse Events; 3.5 Intrinsic and Extrinsic Factors; 3.6 Pre-market Safety Mechanisms; 3.7 Preventing Adverse Medicine Reactions 3.8 Safety of CM and Diabetes ManagementReferences; 4 Integrating Complementary and Conventional Therapies; 4.1 Introduction; 4.2 What is Integration?; 4.3 Concerns about Integration; 4.4 Benefits of Integration; 4.5 Obstacles to Integration; 4.6 How Can Integration Be Achieved?; 4.7 Current Integrative Models; 4.8 Regulatory Issues; 4.9 Responsibilities of Individual Conventional Practitioners Using Complementary Therapies; 4.10 Evidence-based Care and Clinical Practice Guidelines; 4.11 Guidelines for Patients Using Complementary Therapies; 4.12 Quality Use of Medicines 4.13 Documentation and communication4.14 Adverse event reporting; References; 5 Nutritional Therapies; 5.1 Introduction; 5.2 Nutritional Medicine (NM); 5.3 Nutritional Medicine Assessment Approaches; 5.4 The Zone Diet; 5.5 Total Wellbeing Diet; 5.6 Ketogenic or Atkins Diet; 5.7 Metabolic Typing and ABO Blood Type Diets; 5.8 ABO Blood Type Diet; 5.9 The USDA Food Guide Pyramid; 5.10 Detoxification Diets; 5.11 Nutritional Supplementation; 5.12 Vitamins; 5.13 Minerals; 5.15 Essential Fatty Acids; Gamma-Linolenic Acid and Omega 3 Fish Oils; 5.16 Other Key Nutrients; 5.17 Safe Use of Supplements References6 Essential Oils (Aromatherapy); 6.1 Introduction; 6.2 Aromatherapy Care Models; 6.3 Essential Oils; 6.4 Essential Oils and Diabetes Education and Management; 6.5 Precautions to Consider When Assessing the Suitability of Essential Oils in Patients with Renal Disease; 6.6 Essential Oil Use; 6.7 Mental Health and Psychological Care; 6.8 Essential Oil Application/Administration Methods; 6.9 Essential Oil Safety Issues; 6.10 Essential Oil - Conventional Medicine Interactions; References; 7 Counselling and Relaxation Therapies; 7.1 Introduction; 7.2 The Body and the Mind 7.3 Diabetes and the Psyche |
| Record Nr. | UNINA-9910143710903321 |
| Chichester ; ; New York, : J. Wiley, c2006 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Complementary therapies and the management of diabetes and vascular disease [[electronic resource] ] : a matter of balance / / editor, Trish Dunning
| Complementary therapies and the management of diabetes and vascular disease [[electronic resource] ] : a matter of balance / / editor, Trish Dunning |
| Pubbl/distr/stampa | Chichester ; ; New York, : J. Wiley, c2006 |
| Descrizione fisica | 1 online resource (422 p.) |
| Disciplina |
616.462
616.46206 |
| Altri autori (Persone) | DunningTrisha |
| Collana | Diabetes in practice |
| Soggetto topico | Diabetes - Alternative treatment |
| ISBN |
1-280-73987-8
9786610739875 0-470-05743-2 0-470-05742-4 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Complementary Therapies and the Management of Diabetes and Vascular Disease; Contents; Preface; Foreword; List of Contributors; Acknowledgements; 1 Introduction to Diabetes; 1.1 Incidence and Prevalence of Diabetes; 1.2 Overview of Diabetes; 1.3 Management Strategies; 1.4 Management Targets and Regimens; 1.5 Short-term Complications; 1.6 Long-term Complications; 1.7 Psychological Aspects; 1.8 Diabetes Management Requires Integrated Approaches; 1.9 People with Diabetes' Needs, Capacities and Resources; 1.10 Health Professionals' Needs; 1.11 Integration - Is It Possible?
1.12 Complementary Therapies1.13 Summary; References; 2 Complementary Therapy Use; 2.1 Introduction; 2.2 Defining Complementary Therapies; 2.3 What Is Traditional Use?; 2.4 Philosophical Basis of CAM; 2.5 Frequency of CAM Use; 2.6 Profile of Likely CAM Users; 2.7 Culture, Health Beliefs and CAM; 2.8 Reported Adverse Events Associated with CAM; 2.9 Summary; References; 3 Complementary Medicine and Safety; 3.1 Introduction; 3.2 Practices; 3.3 Risks and safety; 3.4 Adverse Events; 3.5 Intrinsic and Extrinsic Factors; 3.6 Pre-market Safety Mechanisms; 3.7 Preventing Adverse Medicine Reactions 3.8 Safety of CM and Diabetes ManagementReferences; 4 Integrating Complementary and Conventional Therapies; 4.1 Introduction; 4.2 What is Integration?; 4.3 Concerns about Integration; 4.4 Benefits of Integration; 4.5 Obstacles to Integration; 4.6 How Can Integration Be Achieved?; 4.7 Current Integrative Models; 4.8 Regulatory Issues; 4.9 Responsibilities of Individual Conventional Practitioners Using Complementary Therapies; 4.10 Evidence-based Care and Clinical Practice Guidelines; 4.11 Guidelines for Patients Using Complementary Therapies; 4.12 Quality Use of Medicines 4.13 Documentation and communication4.14 Adverse event reporting; References; 5 Nutritional Therapies; 5.1 Introduction; 5.2 Nutritional Medicine (NM); 5.3 Nutritional Medicine Assessment Approaches; 5.4 The Zone Diet; 5.5 Total Wellbeing Diet; 5.6 Ketogenic or Atkins Diet; 5.7 Metabolic Typing and ABO Blood Type Diets; 5.8 ABO Blood Type Diet; 5.9 The USDA Food Guide Pyramid; 5.10 Detoxification Diets; 5.11 Nutritional Supplementation; 5.12 Vitamins; 5.13 Minerals; 5.15 Essential Fatty Acids; Gamma-Linolenic Acid and Omega 3 Fish Oils; 5.16 Other Key Nutrients; 5.17 Safe Use of Supplements References6 Essential Oils (Aromatherapy); 6.1 Introduction; 6.2 Aromatherapy Care Models; 6.3 Essential Oils; 6.4 Essential Oils and Diabetes Education and Management; 6.5 Precautions to Consider When Assessing the Suitability of Essential Oils in Patients with Renal Disease; 6.6 Essential Oil Use; 6.7 Mental Health and Psychological Care; 6.8 Essential Oil Application/Administration Methods; 6.9 Essential Oil Safety Issues; 6.10 Essential Oil - Conventional Medicine Interactions; References; 7 Counselling and Relaxation Therapies; 7.1 Introduction; 7.2 The Body and the Mind 7.3 Diabetes and the Psyche |
| Record Nr. | UNINA-9910830285203321 |
| Chichester ; ; New York, : J. Wiley, c2006 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Complementary therapies and the management of diabetes and vascular disease : a matter of balance / / editor, Trish Dunning
| Complementary therapies and the management of diabetes and vascular disease : a matter of balance / / editor, Trish Dunning |
| Pubbl/distr/stampa | Chichester ; ; New York, : J. Wiley, c2006 |
| Descrizione fisica | 1 online resource (422 p.) |
| Disciplina | 616.4/62 |
| Altri autori (Persone) | DunningTrisha |
| Collana | Diabetes in practice |
| Soggetto topico | Diabetes - Alternative treatment |
| ISBN |
9786610739875
9781280739873 1280739878 9780470057438 0470057432 9780470057421 0470057424 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Complementary Therapies and the Management of Diabetes and Vascular Disease; Contents; Preface; Foreword; List of Contributors; Acknowledgements; 1 Introduction to Diabetes; 1.1 Incidence and Prevalence of Diabetes; 1.2 Overview of Diabetes; 1.3 Management Strategies; 1.4 Management Targets and Regimens; 1.5 Short-term Complications; 1.6 Long-term Complications; 1.7 Psychological Aspects; 1.8 Diabetes Management Requires Integrated Approaches; 1.9 People with Diabetes' Needs, Capacities and Resources; 1.10 Health Professionals' Needs; 1.11 Integration - Is It Possible?
1.12 Complementary Therapies1.13 Summary; References; 2 Complementary Therapy Use; 2.1 Introduction; 2.2 Defining Complementary Therapies; 2.3 What Is Traditional Use?; 2.4 Philosophical Basis of CAM; 2.5 Frequency of CAM Use; 2.6 Profile of Likely CAM Users; 2.7 Culture, Health Beliefs and CAM; 2.8 Reported Adverse Events Associated with CAM; 2.9 Summary; References; 3 Complementary Medicine and Safety; 3.1 Introduction; 3.2 Practices; 3.3 Risks and safety; 3.4 Adverse Events; 3.5 Intrinsic and Extrinsic Factors; 3.6 Pre-market Safety Mechanisms; 3.7 Preventing Adverse Medicine Reactions 3.8 Safety of CM and Diabetes ManagementReferences; 4 Integrating Complementary and Conventional Therapies; 4.1 Introduction; 4.2 What is Integration?; 4.3 Concerns about Integration; 4.4 Benefits of Integration; 4.5 Obstacles to Integration; 4.6 How Can Integration Be Achieved?; 4.7 Current Integrative Models; 4.8 Regulatory Issues; 4.9 Responsibilities of Individual Conventional Practitioners Using Complementary Therapies; 4.10 Evidence-based Care and Clinical Practice Guidelines; 4.11 Guidelines for Patients Using Complementary Therapies; 4.12 Quality Use of Medicines 4.13 Documentation and communication4.14 Adverse event reporting; References; 5 Nutritional Therapies; 5.1 Introduction; 5.2 Nutritional Medicine (NM); 5.3 Nutritional Medicine Assessment Approaches; 5.4 The Zone Diet; 5.5 Total Wellbeing Diet; 5.6 Ketogenic or Atkins Diet; 5.7 Metabolic Typing and ABO Blood Type Diets; 5.8 ABO Blood Type Diet; 5.9 The USDA Food Guide Pyramid; 5.10 Detoxification Diets; 5.11 Nutritional Supplementation; 5.12 Vitamins; 5.13 Minerals; 5.15 Essential Fatty Acids; Gamma-Linolenic Acid and Omega 3 Fish Oils; 5.16 Other Key Nutrients; 5.17 Safe Use of Supplements References6 Essential Oils (Aromatherapy); 6.1 Introduction; 6.2 Aromatherapy Care Models; 6.3 Essential Oils; 6.4 Essential Oils and Diabetes Education and Management; 6.5 Precautions to Consider When Assessing the Suitability of Essential Oils in Patients with Renal Disease; 6.6 Essential Oil Use; 6.7 Mental Health and Psychological Care; 6.8 Essential Oil Application/Administration Methods; 6.9 Essential Oil Safety Issues; 6.10 Essential Oil - Conventional Medicine Interactions; References; 7 Counselling and Relaxation Therapies; 7.1 Introduction; 7.2 The Body and the Mind 7.3 Diabetes and the Psyche |
| Record Nr. | UNINA-9911019134603321 |
| Chichester ; ; New York, : J. Wiley, c2006 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Frontiers in clinical drug research -- diabetes and obesity . Volume 3 / / editor, Atta-ur-Rahman, FRS
| Frontiers in clinical drug research -- diabetes and obesity . Volume 3 / / editor, Atta-ur-Rahman, FRS |
| Pubbl/distr/stampa | Sharjah, United Arab Emirates : , : Bentham Books, , 2016 |
| Descrizione fisica | 1 online resource (257 pages) : illustrations, tables |
| Disciplina | 616.462 |
| Collana | Frontiers in Clinical Drug Research -- Diabetes and Obesity |
| Soggetto topico |
Diabetes
Diabetes - Alternative treatment Obesity |
| ISBN | 1-68108-247-0 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910794748503321 |
| Sharjah, United Arab Emirates : , : Bentham Books, , 2016 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Frontiers in clinical drug research -- diabetes and obesity . Volume 3 / / editor, Atta-ur-Rahman, FRS
| Frontiers in clinical drug research -- diabetes and obesity . Volume 3 / / editor, Atta-ur-Rahman, FRS |
| Pubbl/distr/stampa | Sharjah, United Arab Emirates : , : Bentham Books, , 2016 |
| Descrizione fisica | 1 online resource (257 pages) : illustrations, tables |
| Disciplina | 616.462 |
| Collana | Frontiers in Clinical Drug Research -- Diabetes and Obesity |
| Soggetto topico |
Diabetes
Diabetes - Alternative treatment Obesity |
| ISBN | 1-68108-247-0 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910810336003321 |
| Sharjah, United Arab Emirates : , : Bentham Books, , 2016 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
New strategies to advance Pre/Diabetes care : integrative approach by PPPM / / Mahmood S. Mozaffari, editor
| New strategies to advance Pre/Diabetes care : integrative approach by PPPM / / Mahmood S. Mozaffari, editor |
| Edizione | [1st ed. 2013.] |
| Pubbl/distr/stampa | Dordrecht ; ; New York, : Springer, c2013 |
| Descrizione fisica | 1 online resource (548 p.) |
| Disciplina |
616.4
616.46206 |
| Altri autori (Persone) | MozaffariMahmood S |
| Collana | Advances in predictive, preventive and personalised medicine |
| Soggetto topico |
Diabetes - Alternative treatment
Integrative medicine |
| ISBN |
1-299-40833-8
94-007-5971-1 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Global Figures Argue in Favour of Preventive Measures and Personalised Treatment to Optimise Diabetes Care -- Three Levels of Prediction, Prevention & Individualised Treatment Algorithms to Advance Diabetes Care: Integrative Approach -- Diabetes mellitus: new challenges and innovative therapies -- Identification of Biomarkers for beta cell failure as detection tools for predictive screening in type 2 pre-Diabetes -- Endothelial dysfunction in diabetes: role of circulating biomarkers as potential diagnostic and prognostic tolls -- Endothelial progenitor dysfunction in the pathogenesis of diabetic retinopathy: treatment concept to correct diabetes-associated deficits.- Oxidative stress and apoptotic biomarkers in diabetic retinopathy -- Diabetic Retinopathy: the Need for Predictive, Preventive and Personalized Approach to Management -- The role of inflammatory cytokines in diabetic nephropathy: Potential use as predictive markers for early detection and progression -- Preventing hyperglycemia and tissue injury in diabetes: The dynamic role of 2,3 dioxygenase in diabetes and its complications -- An Integrative Approach to Chronic Wounds in Patients with Diabetes: PPPM in Action -- Understanding inflammation as the key to targeted preventive measures for diabetes in relation to periodontics -- Cancer predisposition in diabetics: risk assessment and targeted preventive measures -- Recognition of individual risks by analysis of subcellular imaging insights into chromium picolinate therapy in pre/diabetes care, search into its safety and opinion controversy -- Remote control in diabetes -- Drug delivery systems for predictive medicine: polymers as tools for advanced application. |
| Record Nr. | UNINA-9910438126003321 |
| Dordrecht ; ; New York, : Springer, c2013 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Pathological Mechanisms in Diabetes / / Maria Grau, editor
| Pathological Mechanisms in Diabetes / / Maria Grau, editor |
| Pubbl/distr/stampa | Basel : , : MDPI - Multidisciplinary Digital Publishing Institute, , 2023 |
| Descrizione fisica | 1 online resource (258 pages) |
| Disciplina | 616.462 |
| Soggetto topico | Diabetes - Alternative treatment |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | ger |
| Record Nr. | UNINA-9910729786803321 |
| Basel : , : MDPI - Multidisciplinary Digital Publishing Institute, , 2023 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Structure and health effects of natural products on diabetes mellitus / / Haixia Chen, Min Zhang, editors
| Structure and health effects of natural products on diabetes mellitus / / Haixia Chen, Min Zhang, editors |
| Edizione | [1st ed. 2021.] |
| Pubbl/distr/stampa | Singapore : , : Springer, , [2021] |
| Descrizione fisica | 1 online resource (VIII, 307 p. 85 illus., 16 illus. in color.) |
| Disciplina | 616.462 |
| Soggetto topico |
Diabetes - Alternative treatment
Naturopathy Pharmacology |
| ISBN | 981-15-8791-4 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Chapter 1. Introduction of diabetes melitus and future prospects of natural products on diabetes melitus -- Chapter 2. Anoverview of hypoglycemic modern drugs -- Chapter 3. An overview of hypoglycemic biological drugs -- Chapter 4. An overview of hypoglycemic traditionaldrugs -- Chapter 5. Glycosides from natural sources in the treatment of diabetes mellitus -- Chapter 6. Isolation and Structure Elucidation of Hypoglycemic Compounds -- Chapter 7. Structural Characterization and Health Effects of Polysaccharides from Momordica charantia on Diabetes Mellitus -- Chapter 8. Effects of polysaccharides on reducing blood glucose based on gut microbiota alteration -- Chapter 9. An Overview of Polysaccharides and the influencefactors of Hypoglycemic Activity -- Chapter 10. Plant Secondary Metabolites with α-Glucosidase Inhibitory Activity. - Chapter 11. Rhinacanthin-C and Its Potential to Control Diabetes Mellitus -- Chapter 12. Regeneration of beta cells by inhibition of pro-apoptotic proteins through phytocompound in STZ induced diabetic albino wistar rats-invivo and insilico approach. - Chapter 13. Nitrogenous Compounds from Plant Origin in Management of -- Chapter 14. Plant Alkaloids with Antidiabetic Potential -- Chapter 15. The role of Alkaloids in the Management of Diabetes Mellitus -- Chapter 16. Traditional Indian Herbs for the Management of Diabetes Mellitus and their Herb-Drug Interaction Potentials: An Evidence-Based Review -- Chapter 17. Role of Micronutrients and Trace elements in Diabetes mellitus: A Review. |
| Record Nr. | UNINA-9910483071603321 |
| Singapore : , : Springer, , [2021] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||